Apraclonidine (Sandoz Inc.)
Welcome to the PulseAid listing for the Apraclonidine drug offered from Sandoz Inc.. This Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc. |
NON-PROPRIETARY NAME: | Apraclonidine |
SUBSTANCE NAME: | APRACLONIDINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2009-07-19 |
END MARKETING DATE: | 0000-00-00 |
Apraclonidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Apraclonidine from Sandoz Inc. |
LABELER NAME: | Sandoz Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5.75(mg/mL) |
START MARKETING DATE: | 2009-07-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61314-665_de886297-ac5b-5c43-bf59-b863e5daebd8 |
PRODUCT NDC: | 61314-665 |
APPLICATION NUMBER: | NDA020258 |
Other APRACLONIDINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: